Scope of the Study
Levothyroxine is the most common medication which is prescribed to the patients dealing with hypothyroidism. Levothyroxine is also called by various other names in the market such as T4, thyroxine and symthroid. In hypothyroidism, the thyroid gland gets underactive and becomes unable to generate appropriate amount of thyroid hormone. Levothyroxine works as an analogue hormone which is used for the hormone replacement in the patients dealing with thyroid issues. The constantly rising number of patients suffering from hypothyroidism coupled with the continuously increasing awareness among common masses regarding proper treatment of thyroid issues is acting as a driving factor in the growth of the very market.
The market study is being classified by Type (Tablet and Intravenous Injection) and major geographies with country level break-up.
LGM Pharma (United States), Berlin-Chemie (Germany), Merck Serono (Germany), Bhaarat Pharmaceutical (India), Manus Aktteva (India), Sandoz (Germany), Shenzhen Zhonglian Pharmaceutical (China) and Sichuan Hairong Pharmaceutical (China) are some of the key players profiled in the study.
Research Analyst at AMA predicts that German Players will contribute to the maximum growth of Global Levothyroxine market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Levothyroxine market by Type, Application and Region.
On the basis of geography, the market of Levothyroxine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacy will boost the Levothyroxine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rise in Demand for These Drugs for Hypothyroidism Worldwide
- Increasing issues such as Thyroid Cancer, Especially Among Women
- Availability of Alternative Generic Drugs
- Various Problematic Side Effects of Levothyroxine
- Increasing Government Initiative on Campaigns and Seminars Regarding Women and Maternal Health
- Rise in Thyroid Disorder Patient Population Globally
- Lack of Awareness among People in Developing Economies
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase